SCHEMBL9025613

SCHEMBL9025613

CC(S)NC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 5/20 0.50
KIF11 P52732 1/20 0.38
CYP2D6 P10635 2/20 0.35
CYP1A2 P05177 1/20 0.35
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CACNA1F O60840 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM1 P11229 1/20 0.34
ADRA2B P18089 1/20 0.34
CHRM3 P20309 1/20 0.34
ADRA1A P35348 1/20 0.34
HRH1 P35367 1/20 0.34
OPRK1 P41145 1/20 0.34
CACNA1D Q01668 1/20 0.34
SLC6A3 Q01959 1/20 0.34
KCNH2 Q12809 1/20 0.34
CACNA1S Q13698 1/20 0.34
CACNA1C Q13936 1/20 0.34
SCN5A Q14524 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16673174 1.00 KCNN4 (0.50) KCNN4KIF11CYP2D6CYP1A2MAPK1
SCHEMBL2160833 0.77 KCNN4 (0.50) KCNN4KIF11CYP2D6CYP1A2MAPK1
SCHEMBL4495324 0.77 KCNN4 (0.50) KCNN4KIF11CYP2D6CYP1A2CHRM2
SCHEMBL10675289 0.77 KCNN4 (0.50) KCNN4KIF11CYP2D6CYP1A2MAPK1
SCHEMBL2771122 0.75 CYP1A2 (0.40) KCNN4KIF11CYP2D6CYP1A2ALDH1A1
SCHEMBL19381442 0.74 KCNN4 (0.46) KCNN4KIF11CYP2D6CYP1A2TDP1
SCHEMBL16609226 0.74 KCNN4 (0.52) KCNN4KIF11TDP1CACNA1FCHRM2
SCHEMBL6566499 0.74 KCNN4 (0.52) KCNN4KIF11TDP1CACNA1FCHRM2
SCHEMBL7556522 0.74 KCNN4 (0.46) KCNN4KIF11CYP2D6CYP1A2MAPK1
SCHEMBL2552806 0.72 KCNN4 (0.45) KCNN4KIF11CYP2D6CYP1A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3066106-A1 STABLE PANTETHEINE DERIVATIVES FOR THE TREATMENT OF PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION (PKAN) AND METHODS FOR THE SYNTHESIS OF SUCH COMPOUNDS Acies Bio d.o.o. (SI) 2016-09-14 EP claimed
WO-2015063177-A1 STABLE PANTETHEINE DERIVATIVES FOR THE TREATMENT OF PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION (PKAN) AND METHODS FOR THE SYNTHESIS OF SUCH COMPOUNDS ACIES BIO D.O.O. (SI) 2015-05-07 WO claimed
CN-120059164-A PH responsive polypeptide mimic and preparation method and application thereof 华东理工大学 2025-05-30 CN disclosed
CN-113185740-B Method for improving antibacterial activity and biocompatibility of substrate surface 华东理工大学 2023-09-22 CN disclosed
CN-116554461-A Use of polymers to promote endothelialization of interventional/implant materials 华东理工大学 2023-08-08 CN disclosed
EP-0347749-B1 Pyrazoloacridone derivatives with anti-tumoral activity KYOWA HAKKO KOGYO KK (JP) 1996-04-24 EP disclosed
US-5079358-A Humans; leukemia KYOWA HAKKO KOGYO CO., LTD. (JP) 1992-01-07 US disclosed
EP-0347749-A2 Pyrazoloacridone derivatives with anti-tumoral activity KYOWA HAKKO KOGYO CO., LTD. (JP) 1989-12-27 EP disclosed
EP-0002564-B1 DERIVATIVES OF 7-OXO-1-AZABICYCLO(3.2.0)-HEPT-2-ENE-2-CARBOXYLIC ACID, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES BEECHAM GROUP PLC (GB) 1984-06-20 EP disclosed
US-4347181-A Intermediates for producing bicyclic β-lactam-antibiotics BEECHAM GROUP LIMITED (GB) 1982-08-31 US disclosed
US-4289696-A BETA-LACTAMASE INHIBITORY AGENTS WHICH ENHANCE ACTIVITY OF A PENICICILLIN OR CEPHALOSPORIN BEECHAM GROUP LIMITED (GB) 1981-09-15 US disclosed
US-4223038-A THIENAMYCINS BEECHAM GROUP LIMITED (GB) 1980-09-16 US disclosed
EP-0002564-A1 Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates BEECHAM GROUP PLC (GB) 1979-06-27 EP disclosed